Toolbox Genomics - In the Press

Aug. 3, 2017, PRNewswire --, the world's largest App Store for personal genomics and Toolbox Genomics, a health technology company dedicated to helping people understand and take action on their genetic testing results, announced that the Toolbox Genomics app is now available in's App Store.
Feb. 21, 2017, PRNewswire -- ToolBox Genomics (TBG) today announced the launch of its Health Action Report, which uses consumers' genotype data to develop customized diet, fitness and lifestyle recommendations. The $49 product is currently intended for the 1.5 million individuals who have completed their 23andMe genotyping. TBG plans to make available its own genetic assay later this year for customers who have not yet completed their genetic testing.
Jan 24, 2017, Genome Web -- ToolBox Genomics, a startup that provides customers with nutrition and lifestyle recommendations based on their genotyping profile, said earlier this month that it secured seed funding and plans to begin beta-testing its Health Action Report, which is initially only available to 23andMe customers.
January 17, 2017, Snap Munk -- Genetic testing is kind of a big deal these days. Companies can analyze your DNA to tell you your ancestry, for which diseases you’re at risk, your ability to process caffeine, and the likelihood of you having certain physical characteristics, like male pattern baldness. But despite being able to tell you that you’re primarily Irish with a predisposition toward hearing loss and a high probability of a comb-over, there is still something missing: what do you do with all your genetic information?
January 13, 2017, Nutra Ingredients USA, By Stephen Daniells -- ToolBox Genomics (TBG), a new entrant to the personalized wellness sector, has secured seed round funding and will soon begin beta testing its direct to consumer Health Action Report for customers.
January 11, 2017, Mobi Health News, By Jonah Comstock -- oolbox Genomics, a company that will soon begin to offer actionable health insights based on customers' sequenced genomes, has raised a small round of seed funding, the company told MobiHealthNews. The exact amount of the funding was not disclosed. The company's product will launch in mid-February for $49, CEO Didier Perez told MobiHealthNews.